Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis

International Journal of Oncology

Volumn 30, Issue 6, 2007, Pages 1359-1367

  Sun, Hong Cheng ^a   Qiu, Zheng Jun ^a   Liu, Jun ^a   Sun, Jing ^a   Jiang, Tao ^a   Huang, Ke Jian ^a   Yao, Min ^b   Huang, Chen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Apoptosis; Glut 1; Hypoxia inducible factor 1 (HIF 1); Pancreatic cancer; Prognosis; Survivin; Vascular endothelial growth factor

Indexed keywords

BIRC5 PROTEIN, HUMAN; CD34 ANTIGEN; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1; KI 67 ANTIGEN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ADULT; AGE; AGED; APOPTOSIS; ARTICLE; BIOSYNTHESIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); NICK END LABELING; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SEX DIFFERENCE; SURVIVAL;

ADULT; AGE FACTORS; AGED; ANTIGENS, CD34; APOPTOSIS; CARCINOMA, PANCREATIC DUCTAL; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PROGNOSIS; SEX FACTORS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34447266708     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.30.6.1359     Document Type: Article

References (39)

1. Kallio PJ, Wilson WJ, O'Brien S, Markino Y and Poellinger L: Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 274: 6519-6525, 1999.
2. Zhong H, Chiles K, Feldser D, et al: Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60: 1541-1545, 2000.
3. Talar-Wojnarowska R and Malecka-Panas E: Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications. Med Sci Monit 12: 186-193, 2006.
4. International Union Against Cancer (UICC): Pancreas. In: TNM Classification of Malignant Tumors. Sobin LH and Wittekind C (eds). 5th edition. John Wiley & Sons, Inc., New York, pp87-90, 1997.
5. Kitada T, Seki S, Sakaguchi H, Sawada T, Hirakawa K and Wakasa K: Clinicopathological significance of hypoxia-inducible factor-1alpha expression in human pancreatic carcinoma. Histopathology 43: 550-555, 2003. (Pubitemid 38002343)
6. Zhong H, De Marzo AM, Laughner E, et al: Over-expression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59: 5830-5835, 1999.
7. Sarela AI, Verbeke CS, Ramsdale J, Davies CL, Markham AF and Guillou PJ: Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein in pancreatic cancer. Br J Cancer 86: 886-892, 2002.
8. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M and Tanigawa N: Expression of survivin and its relationship to loss of apoptosis in breast carcinoma. Clin Cancer Res 6: 127-134, 2000. (Pubitemid 30064984)
9. Kuwai T, Kitadai Y, Tanaka S, et al: Expression of hypoxia-inducible factor-1 alpha is associated with tumor vascularizaion in human colorectal carcinoma. Int J Cancer 105: 176-181, 2003.
10. Theodoropoulos VE, Lazaris AC, Kastriotis I, et al: Evaluation of hypoxia-inducible factor-1 alpha overexpression as a predictor of tumor recurrence and progression in superficial urothelial bladder carcinoma. BJU Int 95: 425-431, 2005.
11. Shibaji T, Nagao M, Ikeda N, et al: Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer. Anticancer Res 23: 4721-4727, 2003. (Pubitemid 38173890)
12. Chun YS, Kim MS and Park JW: Oxygen-dependent and - independent regulation of HIF-1alpha. J Korean Med Sci 17: 581-588, 2002.
13. Urano N, Fujiwara Y, Doki Y, et al: Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma. Gastric Cancer 9: 44-49, 2006.
14. Mizokami K, Kakeji Y, Oda S, et al: Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas. J Surg Oncol 94: 149-154, 2006. (Pubitemid 44267197)
15. Theodoropoulos VE, Lazaris AC, Sofras F, et al: Hypoxia-inducible factor 1alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol 46: 200-208, 2004.
16. Huang GW, Yang LY and Lu WQ: Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: impact on neovascularization and survival. World J Gastroenterol 11: 1705-1708, 2005.
17. Jiang CQ, Fan LF, Liu ZS, et al: Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma Clin Med J 117: 1541-1546, 2004.
18. Buchler P, Reber HA, Buchler M, et al: Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas 26: 56-64, 2003. (Pubitemid 36020267)
19. Choi KS, Bae MK, Jeong JW, Moon HE and Kim KW: Hypoxia-induced angiogenesis during carcinogenesis. J Biochem Mol Biol 36: 120-127, 2003.
20. Ikeda N, Adachi M, Taki T, et al: Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 79: 1553-1563, 1999.
21. Linder S, Blasjo M, von Rosen A, Parrado C, Falkmer UG and Falkmer S: Pattern of distribution and prognostic value of angiogenesis in pancreatic duct carcinoma: a semiquantitative immunohistochemical study of 45 patients. Pancreas 22: 240-247, 2001.
22. Younes M, Lechago LV, Somoano JR, Mossharaf M and Lechago J: Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res 56: 1164-1167, 1996. (Pubitemid 26065417)
23. Akakura N, Kobayashi M, Horiuchi I, et al: Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res 61: 6548-6554, 2001.
24. Cooper R, Sarioglu S, Sokmen S, et al: Glucose transporter-1 (Glut-1): a potential marker of prognosis in rectal carcinoma. Br J Cancer 89: 870-876, 2003.
25. Haber RS, Rathan A, Weiser KR, et al: Glut-1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 83: 34-40, 1998.
26. Ambrosini G, Adida C and Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921, 1997. (Pubitemid 27353455)
27. Lee MA, Park GS, Lee HJ, et al: Survivin expression and its clinical significance in pancreatic cancer. BMC Cancer 5: 127, 2005.
28. Qiao JG, Zhang YQ, Yin YC and Tan Z: Expression of survivin in pancreatic cancer and its correlation to expression of Bcl-2. World J Gastroenterol 10: 2759-2761, 2004.
29. Kami K, Doi R, Koizumi M, et al: Survivin expression is a prognostic marker in pancreatic cancer patients. Surgery 136: 443-448, 2004.
30. Satoh K, Kaneko K, Hirota M, Masamune A, Satoh A and Shimosegawa T: Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 92: 271-278, 2001. (Pubitemid 32664432)
31. Bhanot U, Heydrich R, Moller P and Hasel C: Survivin expression in pancreatic intraepithelial neoplasia (PanIN): steady increase along the developmental stages of pancreatic ductal adenocarcinoma. Am J Surg Pathol 30: 754-759, 2006.
32. Wei H, Wang C and Chen L: Proliferating cell nuclear antigen, survivin, and CD34 expressions in pancreatic cancer and their correlation with hypoxia-inducible factor 1alpha. Pancreas 32: 159-163, 2006.
33. Chang Q, Qin R, Huang T, Gao J and Feng Y: Effect of antisense hypoxia-inducible factor 1alpha on progression, metastasis, and chemosensitivity of pancreatic cancer. Pancreas 32: 297-305, 2006. (Pubitemid 43753972)
34. Chen J, Zhao S, Nakada K, et al: Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol 162: 1283-1291, 2003.
35. Greijer AE and van der Wall E: The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 57: 1009-1014, 2004.
36. Piret JP, Mottet D, Raes M and Michiels C: Is HIF-1alpha a proor an anti-apoptotic protein? Biochem Parmacol 64: 889-892, 2002.
37. Vleugel MM, Greijer AE, Shvarts A, et al: Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol 58: 172-177, 2005.
38. Bos R, van der Groep P, Greijer AE, et al: Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97: 1573-1581, 2003.
39. Schindl M, Schoppmann SF, Samonigg H, et al: Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 8: 1831-1837, 2002.